![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 05, 2017 7:40:14 PM
"No, that is not correct. I don’t remember the exact timeline, but we updated the clinical trials website late last year or early this year. We updated the status to indicate the trial is now closed at all sites. Until late last year we had a single site remaining open in the UK. Analysis of the data will commence when we get the financing we are seeking finalized. At that time we’ll provide the investigators with the data and a draft of the conclusions for them to review and circulate among the authors. I am sure they will seek publication in a journal, a process that takes 6-9 months. In order to get published, the results of MORDIS cannot be released in any other format.
We are finishing up the draft of the K which will be supplied to our auditors for their review. Our auditors will be on site here in San Diego, make their final comments, review those comments with our board’s audit committee and released before the end of March.
Hope this information is helpful to you.
Regards.
Mike"
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM